NO20090819L - (S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette - Google Patents

(S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette

Info

Publication number
NO20090819L
NO20090819L NO20090819A NO20090819A NO20090819L NO 20090819 L NO20090819 L NO 20090819L NO 20090819 A NO20090819 A NO 20090819A NO 20090819 A NO20090819 A NO 20090819A NO 20090819 L NO20090819 L NO 20090819L
Authority
NO
Norway
Prior art keywords
hydrate
pharmaceutical composition
camylate
amlopidine
pinamyl
Prior art date
Application number
NO20090819A
Other languages
English (en)
Norwegian (no)
Inventor
Jaeheon Lee
Moon Sub Lee
Weon Ki Yang
Jeaho Yoo
Jae-Chul Lee
Chang-Ju Choi
Han Kyong Kim
Young-Kill Chang
Gwansun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of NO20090819L publication Critical patent/NO20090819L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
NO20090819A 2006-07-21 2009-02-20 (S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette NO20090819L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060068401A KR100913791B1 (ko) 2006-07-21 2006-07-21 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
PCT/KR2007/003444 WO2008010659A1 (en) 2006-07-21 2007-07-16 (s)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same

Publications (1)

Publication Number Publication Date
NO20090819L true NO20090819L (no) 2009-02-20

Family

ID=38956963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090819A NO20090819L (no) 2006-07-21 2009-02-20 (S)-(-)-amlopidinkamsylat eller hydrat derav og farmasoytisk preparat omfattende dette

Country Status (19)

Country Link
US (1) US20090326234A1 (pt)
EP (1) EP2044022A1 (pt)
JP (1) JP2009544695A (pt)
KR (1) KR100913791B1 (pt)
CN (1) CN101495451B (pt)
AR (1) AR062009A1 (pt)
AU (1) AU2007276038B2 (pt)
BR (1) BRPI0714313A2 (pt)
CA (1) CA2658384C (pt)
EC (1) ECSP089024A (pt)
IL (1) IL196318A0 (pt)
MX (1) MX2009000454A (pt)
MY (1) MY152884A (pt)
NO (1) NO20090819L (pt)
NZ (1) NZ574006A (pt)
RU (1) RU2403241C1 (pt)
UA (1) UA93724C2 (pt)
WO (1) WO2008010659A1 (pt)
ZA (1) ZA200900231B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA33056B1 (fr) 2009-01-23 2012-02-01 Hanmi Holding Co Ltd Composition pharmaceutique solide comprenant de l'amlodipine et du losartan et son procede de fabrication
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
KR102521227B1 (ko) * 2018-09-12 2023-04-13 후지필름 가부시키가이샤 약액, 기판의 처리 방법
CN113041244B (zh) 2019-11-08 2022-06-21 施慧达药业集团(吉林)有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
PL189666B1 (pl) * 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
WO2002079518A1 (en) 2001-03-29 2002-10-10 Chugai Seiyaku Kabushiki Kaisha A method for genotyping individuals for multiple snps
KR100452491B1 (ko) * 2001-03-29 2004-10-12 한미약품 주식회사 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
CN1152013C (zh) * 2001-11-22 2004-06-02 张喜田 一类左旋氨氯地平盐的水合物及其制剂
KR20040011751A (ko) * 2002-07-30 2004-02-11 씨제이 주식회사 암로디핀의 유기산염
EP1587792B1 (en) * 2003-01-27 2014-08-27 Hanmi Science Co., Ltd. Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
KR100841409B1 (ko) * 2003-12-16 2008-06-25 에스케이케미칼주식회사 암로디핀 겐티세이트 염과 이의 제조방법
ES2307209T3 (es) * 2004-10-20 2008-11-16 Emcure Pharmaceuticals Limited Procedimiento de produccion de un enantiomero de amlodipina con una pureza optica alta.
GB0502509D0 (en) * 2005-02-07 2005-03-16 Pfizer Ltd Novel salt form of a dopamine agonist

Also Published As

Publication number Publication date
RU2403241C1 (ru) 2010-11-10
AU2007276038B2 (en) 2011-06-16
JP2009544695A (ja) 2009-12-17
MY152884A (en) 2014-11-28
ZA200900231B (en) 2010-04-28
KR20080008752A (ko) 2008-01-24
MX2009000454A (es) 2009-01-28
KR100913791B1 (ko) 2009-08-26
AU2007276038A1 (en) 2008-01-24
WO2008010659A1 (en) 2008-01-24
IL196318A0 (en) 2009-09-22
AR062009A1 (es) 2008-08-10
ECSP089024A (es) 2009-01-30
CA2658384C (en) 2012-01-17
NZ574006A (en) 2010-09-30
RU2009106073A (ru) 2010-08-27
CN101495451A (zh) 2009-07-29
EP2044022A1 (en) 2009-04-08
CA2658384A1 (en) 2008-01-24
UA93724C2 (ru) 2011-03-10
US20090326234A1 (en) 2009-12-31
BRPI0714313A2 (pt) 2013-04-02
CN101495451B (zh) 2012-07-25

Similar Documents

Publication Publication Date Title
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
NO20084747L (no) Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
WO2008036765A3 (en) Micrornas differentially expressed in pancreatic diseases and uses thereof
WO2008112022A8 (en) 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
WO2008067219A3 (en) Quinazolinone modulators of tgr5
WO2009027346A3 (de) 17beta-hydroxysteroid-dehydrogenase-typ1-inhibitoren zur behandlung hormonabhängiger erkrankungen
WO2008008887A3 (en) Gpr119 agonists for treating metabolic disorders
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
WO2009153496A3 (fr) Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies
WO2007109024A3 (en) Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
WO2008131150A3 (en) New urethane (meth)acrylates and their use in curable coating compositions
WO2007115305A3 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
WO2009026334A3 (en) Treatment with kallikrein inhibitors
WO2007087575A3 (en) Compositions and methods for treating pulmonary hypertension
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
WO2007125105A3 (en) Benzamide glucokinase activators
WO2010005565A3 (en) Method of treating glycogen storage disease
DK2467364T3 (da) Nitrogen-holdige forbindelser og farmaceutiske sammensætninger for behandling af atrial flimren.
WO2010077339A3 (en) β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
DK1994005T3 (da) Tetrahydronaphthalinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelseshæmmere

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application